PMID: 9171941Jun 1, 1997Paper

Endotoxin alters the systemic disposition of nitric oxide synthase inhibitors in the awake sheep

Clinical and Experimental Pharmacology & Physiology
A J RuttenM J Whiting

Abstract

1. We evaluated the haemodynamic effects and systemic disposition of the nitric oxide synthase (NOS) inhibitor NL-nitro-L-arginine (NOLA) after intravenous (i.v.) administration of two different doses (5 and 20 mg/kg) in awake healthy sheep and awake sheep given a continuous i.v. infusion of endotoxin (lipopolysaccharide, 12 ng/kg per h, i.v., for 18 h). In addition, we determined the systemic disposition of another NOS inhibitor, NL-nitro-L-arginine methylester (L-NAME; 20 mg/kg, i.v.) in awake healthy sheep only. 2. NL-Nitro-L-arginine produced a dose-dependent decrease in heart rate (HR) and cardiac output (CO) together with a dose-dependent increase in mean arterial pressure (MAP) and peripheral vascular resistance (PVR) when compared to baseline. In endotoxic sheep NOLA produced a greater increase in MAP and mean pulmonary arterial pressure (MPAP). 3. In healthy sheep there was a dose-related increase in total body clearance (Cl) of NOLA. The Cl increased from 0.028 L/min after the lower dose to 0.032 L/min after the higher dose. The infusion of endotoxin caused an increase in Cl of NOLA to 0.040 and 0.047 L/min, respectively, and a decrease in plasma slow half-life (t1/2) from 825 to 546 min and from 780 to 453 min, respe...Continue Reading

References

Aug 1, 1979·Circulation Research·K L BrighamJ Haynes
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A Zembowicz, J R Vane
Jun 1, 1992·Journal of Cardiovascular Pharmacology·B ZingarelliA P Caputi
May 1, 1992·Journal of Vascular Research·S Schwarzacher, G Raberger
Aug 6, 1991·European Journal of Pharmacology·I FlemingJ C Stoclet
Dec 1, 1991·Clinical and Experimental Pharmacology & Physiology·C K NarkowiczX F Xu
Nov 1, 1990·British Journal of Pharmacology·D D ReesS Moncada
May 1, 1991·Clinical and Experimental Pharmacology & Physiology·J J TreshamJ A Whitworth
Nov 1, 1991·Infection and Immunity·S D FlemingS K Chapes
Nov 1, 1991·Annals of Surgery·J B OchoaA B Peitzman
Jan 1, 1985·Annual Review of Pharmacology and Toxicology·L J Ignarro, P J Kadowitz
Jan 1, 1988·Journal of Medical Genetics·A SmithG den Dulk
Nov 1, 1993·British Journal of Pharmacology·M J GriffithsT W Evans
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·C M Martin, W J Sibbald
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C ThiemermannJ R Vane
Mar 16, 1993·European Journal of Pharmacology·T P MiskoM G Currie
Mar 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·K KrejcyG Raberger
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T MichelL Busconi
Oct 3, 1994·Journal of Chromatography. B, Biomedical Applications·M J WhitingA D Bersten
May 1, 1993·Critical Care Medicine·J A LorenteD Liste
Sep 1, 1995·Clinical and Experimental Pharmacology & Physiology·M H YenC C Wu

❮ Previous
Next ❯

Citations

Feb 13, 2007·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Orjan GribbeN P Wiklund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.